Only 16% Of Supplement Makers Surveyed Report AEs To FDA - GMP Study
This article was originally published in The Tan Sheet
Executive Summary
A scant 37 (16% of 238) dietary supplement establishments that responded to an FDA manufacturing practices survey said they report consumer complaints of adverse events to FDA.
You may also be interested in...
Supplement GMPs On CFSAN's Autumn "Must Do" List, Levitt Tells CRN
Dietary supplement Good Manufacturing Practices are on the Center for Food Safety & Applied Nutrition's "must do" list for this fall, although a proposed reg will not be issued by the Sept. 30 target deadline, CFSAN Director Joseph Levitt reported.
Fixed-Combination OTCs Derived From Botanicals Due For Rulemaking
A proposed rule on fixed-combination OTC products derived from natural sources, including animal and botanical raw materials, could be issued by FDA as early as July, according to the agency's "unified agenda" published in the Federal Register April 24.
Supplement Manufacturing Practices Survey Proposed By FDA
FDA is proposing to conduct a survey of dietary supplement companies' existing manufacturing practices for use in developing its proposed rule on industry-wide GMP standards, the agency says in an Oct. 6 Federal Register notice.